CAR T cell therapy–related cardiovascular outcomes and management: systemic disease or direct cardiotoxicity?
CD19-specific chimeric antigen receptor (CAR) T cell therapies have shown remarkable
early success in highly refractory and relapsing hematological malignancies. However, this …
early success in highly refractory and relapsing hematological malignancies. However, this …
BSE and BCOS guideline for transthoracic echocardiographic assessment of adult cancer patients receiving anthracyclines and/or trastuzumab
The subspecialty of cardio-oncology aims to reduce cardiovascular morbidity and mortality
in patients with cancer or following cancer treatment. Cancer therapy can lead to a variety of …
in patients with cancer or following cancer treatment. Cancer therapy can lead to a variety of …
[HTML][HTML] Cardiotoxicity of chemotherapy and targeted agents
TW Mudd Jr, M Khalid, AK Guddati - American Journal of Cancer …, 2021 - ncbi.nlm.nih.gov
The evolution of cancer treatment and development of new classes of anticancer therapies
have continued to revolutionize the field of oncology. New therapies including targeted …
have continued to revolutionize the field of oncology. New therapies including targeted …
Role of cardiovascular magnetic resonance imaging in cardio-oncology
CED Saunderson, S Plein… - European Heart Journal …, 2021 - academic.oup.com
Advances in cancer therapy have led to significantly longer cancer-free survival times over
the last 40 years. Improved survivorship coupled with increasing recognition of an …
the last 40 years. Improved survivorship coupled with increasing recognition of an …
Multimodality cardiac imaging in the era of emerging cancer therapies
Recently, the field of oncology has witnessed a surge of new therapeutic agents that have
collectively led to improved rates of progression-free and overall survival for many cancers …
collectively led to improved rates of progression-free and overall survival for many cancers …
Cardio‐oncology care in the era of the coronavirus disease 2019 (COVID‐19) pandemic: an International Cardio‐Oncology Society (ICOS) statement
D Lenihan, J Carver, C Porter, JE Liu… - CA: a cancer journal …, 2020 - Wiley Online Library
The severe acute respiratory syndrome coronavirus 2 (SARS–CoV‐2) has given rise to a
pandemic of unprecedented proportions in the modern era because of its highly contagious …
pandemic of unprecedented proportions in the modern era because of its highly contagious …
British Society for Echocardiography and British Cardio-Oncology Society guideline for transthoracic echocardiographic assessment of adult cancer patients receiving …
The subspecialty of cardio-oncology aims to reduce cardiovascular morbidity and mortality
in patients with cancer or following cancer treatment. Cancer therapy can lead to a variety of …
in patients with cancer or following cancer treatment. Cancer therapy can lead to a variety of …
Detection of anticancer drug-induced cardiotoxicity using VCAM1-targeted nanoprobes
Chemotherapy-induced cardiac toxicity is an undesirable yet very common effect that
increases the risk of death and reduce the quality of life of individuals undergoing …
increases the risk of death and reduce the quality of life of individuals undergoing …
Early diagnosis of chemotherapy-induced cardiotoxicity by cardiac MRI
R Cau, P Bassareo, V Cherchi, V Palmisano… - European Journal of …, 2020 - Elsevier
Survival rate in cancer patients has improved over the course of the years. In cancer
survivors, cardiovascular disease is the second leading cause of mortality and early …
survivors, cardiovascular disease is the second leading cause of mortality and early …
Contribution of membrane transporters to chemotherapy‐induced cardiotoxicity
Membrane transporters play a key role in determining the pharmacokinetic profile,
therapeutic safety, and efficacy of many chemotherapeutic drugs by regulating cellular influx …
therapeutic safety, and efficacy of many chemotherapeutic drugs by regulating cellular influx …